Articles

Raymond James downgrades Scott’s Miracle Gro to market perform after stock rises 15% in 2024.

Another analyst has joined the bull camp on shares of Super Micro, which have experienced a nearly 800% surge over the past 12 months.

Over the past 70 years, the first two weeks of April have boosted U.S. stocks.

Increased market interest and speculative activity potentially leads to short-term price surges.

Tesla’s stock fell Monday toward a third-straight loss of more than 1%, after the electric-vehicle giant lost another bullish backer — one who said slowing demand, rising inventories and tightening liquidity should hurt results over the next year.

Why gold-mining stocks look set to outperform physical gold.

Goldman Sachs lays out a scenario for the S&P 500 to hit 6,000 by the end of the year thanks to Big Tech.

35 major U.S. corporations have paid less than nothing in federal income taxes. Instead, they collectively netted almost $2 billion in refunds.

A long-overdue step toward giving investors crucial information to make informed decisions.

Politan Capital plans to nominate two more board members to Masimo.

Where are we going to get the workers to care for us? How are we going to pay them?

Novo Nordisk, the Danish pharmaceutical whose market cap has swelled due to popular weight loss drugs, on Monday announced it was making an acquisition targeting cardiovascular disease.